Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933543 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)
A Phase 2 study of Acne Vulgaris, sponsored by Photocure.
- Completed
- Registry status
- Phase 2
- Development phase
- 107
- Enrollment target
- 11
- Study locations
NCT00933543: Completed Phase 2 study of Acne Vulgaris, sponsored by Photocure.
NCT00933543 is a Phase 2 study of Acne Vulgaris that has completed, run by Photocure. The registered enrollment target is 107 participants, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (61% lower). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00933543, a Phase 2 study of Acne Vulgaris, has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 107 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this trial is to study the efficacy and safety of Visonac PDT in patients from 9 to 35 years old with Aktilite® CL512. Patients was randomized to Visonac or vehicle cream without occlusion and red light(dose: 37J/cm2)
Conditions Studied
Interventions
- PROCEDURE PDT
- DRUG Visonac PDT (MAL PDT)
- DRUG Vehicle cream (placebo)
Study Locations (11)
Illinois
- DeNova Research - Chicago
- Dermatology Institute of DuPage Medical Group - Naperville
Quebec
- INNOVADERM Research Inc. - Montreal
- Centre de Recherche Dermatologique - Québec
California
- Children's Specialists of San Diego / Rady Children's Hospital San Diego - San Diego
Minnesota
- Minnesota Clinical Study Center - Fridley
New York
- Dermatology Associates of Rochester - Rochester
Pennsylvania
- Milton S. Hershey Medical Center - Hershey
Virginia
- Virginia Clinical Research, Inc. - Norfolk
Wisconsin
- Madison Skin & Research, Inc - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
What the finished NCT00933543 record still lists
NCT00933543 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 3 interventions - of which PDT is the first listed.
NCT00933543 lists 11 locations in 9 states (Illinois, Quebec, California).
Frequently Asked Questions
What is clinical trial NCT00933543 about?
NCT00933543 is a clinical study titled "Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)". The purpose of this trial is to study the efficacy and safety of Visonac PDT in patients from 9 to 35 years old with Aktilite® CL512. Patients was randomized to Visonac or vehicle cream without occlusion and red light(dose: 37J/cm2)
What is the current status of trial NCT00933543?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 107 participants. The study started on 2009-08. Estimated completion is 2010-03.
What conditions does trial NCT00933543 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT00933543?
The interventions under investigation include: PDT (PROCEDURE), Visonac PDT (MAL PDT) (DRUG), Vehicle cream (placebo) (DRUG).
Who is sponsoring clinical trial NCT00933543?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00933543 being conducted?
This trial has 11 study locations across California, Illinois, Minnesota, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00933543's enrollment target sits among peer trials
107 38th of 67 higher than 30 of 67 other Acne Vulgaris trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne Vulgaris trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
ACTIVE NOT RECRUITING · Phase 2
-
Dose Range Study of CD5789 in Acne Vulgaris
COMPLETED · Phase 2
-
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
COMPLETED · Phase 2
-
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris
COMPLETED · Phase 2
-
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
COMPLETED · Phase 2
-
A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia